Tai Chi for Patients With Essential Hypertension
- Conditions
- Hypertension
- Interventions
- Behavioral: Tai ChiBehavioral: Walking
- Registration Number
- NCT04267471
- Lead Sponsor
- Chengdu University of Traditional Chinese Medicine
- Brief Summary
Several studies investigating Tai Chi for hypertension have been carried out. However, investigators found the results were in high heterogeneity and poor methodological quality. Thus, investigators intend to provide high quality of the effectiveness and safety of Tai Chi for essential hypertension.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 234
- participants aged between 45 to 80 years;
- participants diagnosed with mild to moderate hypertension, and meet the diagnostic criteria of mild to moderate hypertension according to 2018 Chinese guidelines for the management of hypertension (140≤SBP≤169 and/or 90≤DBP≤109);
- participants with or without antihypertensive medication;
- participants with no regular exercise in the past 3 months;
- participants willing to comply with the study protocol;
- participants willing to sign informed consent form.
- participants diagnosed with secondary hypertension or refractory hypertension;
- participants with severe medical visceral condition and chronic diseases, such as diabetes, epilepsy, severe depression or anxiety, psychosis;
- participants with severe bone and joint diseases or motor dysfunction limit ability to participant exercise;
- participants with severe cognitive decline (Mini-Mental State Examination score, ≤ 20)
- participants with weak muscle, poor balance or limited vision that would impede full participation in the study;
- patients participate in other clinical trials at the same time.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Tai Chi Tai Chi 3 sessions of Tai Chi per week for 12 weeks Walking Walking 3 sessions of walking per week for 12 weeks
- Primary Outcome Measures
Name Time Method average 24-h Systolic Blood Pressure (SBP) change from baseline to 12 weeks after intervention
- Secondary Outcome Measures
Name Time Method average SBP and average Diastolic Blood Pressure (DBP) baseline, after intervention(12 week), after follow-up(24 week) average SBP and average DBP during the daytime and night-time
change of serum concentrations of Nitric Oxide baseline, after intervention(12 week) change of serum concentrations of vascular endothelial growth factor baseline, after intervention(12 week) change of serum concentrations of endothelin baseline, after intervention(12 week) blood pressure measured at home with an upper arm electronic sphygmomanometer baseline, after intervention(12 week), after follow-up(24 week) change of serum concentrations of thromboxane A2 baseline, after intervention(12 week) Medical Outcomes Study 36-Item Short Form baseline, after intervention(12 week) This scale contains eight dimensions (physical function, role physical, bodily pain, general health, vitality, social function, role emotional, mental health) and two summary components (physical and mental), with score from 0 to 100. High scores indicate a better quality of life.
Trial Locations
- Locations (1)
Affiliated Hospital of Chengdu University of Traditional Chinese Medicine (Sichuan Provincial Hospital of Traditional Chinese Medicine)
🇨🇳Chengdu, Sichuan, China